Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical Characteristics and Prognosis of Secondary Acute Lymphoblastic Leukemia in Patients with Multiple Myeloma during Long-Term Thalidomide Maintenance. | J Pers Med | 2023 | 36983594 | PubTator, text mining | PubMed |
| Regulation of Cell Plasticity by Bromodomain and Extraterminal Domain (BET) Proteins: A New Perspective in Glioblastoma Therapy. | Int J Mol Sci | 2023 | 36982740 | PubTator, text mining | PubMed |
| Emerging Strategies in Proteolysis-Targeting Chimeras (PROTACs): Highlights from 2022. | Int J Mol Sci | 2023 | 36982263 | PubTator, text mining | PubMed |
| Discovery of a Potent and Selective Targeted NSD2 Degrader for the Reduction of H3K36me2. | J Am Chem Soc | 2023 | 36976643 | PubTator, text mining | PubMed |
| Small Molecule Degraders of Protein Tyrosine Phosphatase 1B and T-Cell Protein Tyrosine Phosphatase for Cancer Immunotherapy. | Angew Chem Int Ed Engl | 2023 | 36973833 | PubTator, text mining | PubMed |
| Targeted Small Molecules for Systemic Lupus Erythematosus: Drugs in the Pipeline. | Drugs | 2023 | 36972009 | PubTator, text mining | PubMed |
| Structural rationalization of GSPT1 and IKZF1 degradation by thalidomide molecular glue derivatives. | RSC Med Chem | 2023 | 36970148 | PubTator, text mining | PubMed |
| Targeted therapies for the treatment of soft tissue sarcoma. | Front Oncol | 2023 | 36969064 | PubTator, text mining | PubMed |
| Targeted therapy based on ubiquitin-specific proteases, signalling pathways and E3 ligases in non-small-cell lung cancer. | Front Oncol | 2023 | 36969062 | PubTator, text mining | PubMed |
| Chemical Knockdown of Phosphorylated p38 Mitogen-Activated Protein Kinase (MAPK) as a Novel Approach for the Treatment of Alzheimer's Disease. | ACS Cent Sci | 2023 | 36968534 | PubTator, text mining | PubMed |
| Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis. | Inflammopharmacology | 2023 | 36966238 | PubTator, text mining | PubMed |
| Efficacy and safety of pomalidomide, bortezomib, and dexamethasone combination chemotherapy for newly diagnosed multiple myeloma: POMACE Phase II Study. | Blood Cancer J | 2023 | 36964143 | PubTator, text mining | PubMed |
| Small-molecule correctors and stabilizers to target p53. | Trends Pharmacol Sci | 2023 | 36964053 | PubTator, text mining | PubMed |
| High Accuracy Prediction of PROTAC Complex Structures. | J Am Chem Soc | 2023 | 36961978 | PubTator, text mining | PubMed |
| Construction of copy number variation landscape and characterization of associated genes in a Bangladeshi cohort of neurodevelopmental disorders. | Front Genet | 2023 | 36959829 | PubTator, text mining | PubMed |
| Discovery of Potent and Highly Selective Interleukin-2-Inducible T-Cell Kinase Degraders with In Vivo Activity. | J Med Chem | 2023 | 36959108 | PubTator, text mining | PubMed |
| Discovery of Nanomolar DCAF1 Small Molecule Ligands. | J Med Chem | 2023 | 36948210 | PubTator, text mining | PubMed |
| PROTAC-Mediated Selective Degradation of Cytosolic Soluble Epoxide Hydrolase Enhances ER Stress Reduction. | ACS Chem Biol | 2023 | 36947831 | PubTator, text mining | PubMed |
| Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy. | Blood Cancer J | 2023 | 36944635 | PubTator, text mining | PubMed |
| Targeted Protein Degradation through E2 Recruitment. | ACS Chem Biol | 2023 | 36940189 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=40